“Cannabis-Based Product Use in Multiple Sclerosis: A Swiss Nationwide, Registry-Based Observational Study”. Swiss Medical Weekly, vol. 156, no. 11, Nov. 2026, p. 4747, https://doi.org/10.57187/4747.